Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Growth Portfolio Rebalancing  -  EXIT (TSXV: ALV) and ENTRY (TSXV: NURS)

Jan 02, 2026 | Team Kalkine
Growth Portfolio Rebalancing  -  EXIT (TSXV: ALV) and ENTRY (TSXV: NURS)

  • ALV:TSX-V
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (CA$)
  • NURS:TSX-V
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (CA$)

1. Exit Case: Alvopetro Energy Ltd 

Overview:

Alvopetro Energy Ltd (TSXV: ALV) is a Canada-based resource company engaged in the exploration, acquisition, development, and production of hydrocarbons in Brazil. It generates revenue from Natural gas, oil, and condensate sales, and all of its revenue is derived from Brazil.

ALV has been a part of the ‘Growth Portfolio’ since 13 November, 2025, however, considering the recent rise in the share price of the stock, an ‘Exit’ is recommended from the stock at the last closing price of CAD 6.99, as on 31 December 2025. 

1.1 Support and Resistance Summary as provided in our last published report dated 13 November 2025.

1.2 Alvopetro Energy Ltd

 2. New Entry Case: Hydreight Technologies Inc 

Overview:  

Hydreight Technologies Inc. (TSXV: NURS) is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform has hosted a network of over 3000 nurses, over 300 doctors and a pharmacy network through its Doctor networks across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.

Technical Analysis:

On the daily chart, NURS has maintained a broader upward trend through most of 2025, rising steadily from the CAD 2.00 levels earlier in the year and currently trading around CAD 4.7. After peaking near the CAD 5.00 zone in November, the stock saw a brief pullback but has since stabilised and resumed sideways-to-positive consolidation, indicating that buyers continue to defend higher levels rather than exit aggressively. The RSI is currently around 56.6089, pointing to healthy momentum without entering overbought territory, which suggests the rally is consolidating rather than exhausting. Key support lies at CAD 4.11, while the next major resistance level to watch is CAD 5.67.

Considering the above mentioned factors, technical analysis, support & resistance levels, an ‘Entry’ is recommended in the ‘Growth Portfolio’ at the closing market price of CAD 4.73, as on 31 December 2025. 

2.1 Support and Resistance Summary (as on 31 December 2025)

 2.2 Hydreight Technologies Inc

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency as of 31 December 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings.

Disclaimer

This information should not be relied upon as personal financial advice by Kalkine on (i) the stocks or (ii) the use or suitability of the model portfolios. Only an investor knows about their circumstances to make an investment decision.

Model Portfolio has been prepared for illustrative purpose only and does not take into account the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on the information, consider its appropriateness, having regard to their objectives, financial situation and needs. Past performance is not necessarily indicative of future performance results. Actual investment returns will vary, and the Growth of investments can go up or down.


Disclaimer-

The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.

Support

Hi! How can we help you today?

Loading…